US Stock MarketDetailed Quotes
DRTSW ALPHA TAU MEDICAL LTD C/WTS 07/03/2027 (TO PUR COM)
- 0.2600
- +0.0239+10.12%
Close May 3 16:00 ET
0Market Cap0.00P/E (TTM)
0.2600High0.2103Low9.11KVolume0.2104Open0.2361Pre Close2.18KTurnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.452652wk High0.00P/B0Float Cap0.140052wk Low--Dividend TTM0Shs Float1.0599Historical High--Div YieldTTM21.05%Amplitude0.1400Historical Low0.2390Avg Price1Lot Size
ALPHA TAU MEDICAL LTD C/WTS 07/03/2027 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | 24.80%-17.96M | -102.16%-23.88M | -290.49%-8.74M | -110.52%-6.59M | -62.90%-11.81M | -2.24M | -3.13M | -4.93%-7.25M | -6.91M |
| Net income from continuing operations | 13.64%-29.16M | -23.80%-33.76M | 71.37%-2M | -119.83%-25.74M | -207.04%-27.27M | ---6.98M | ---11.71M | -4.94%-8.88M | ---8.46M |
| Operating gains losses | -153.67%-2.03M | -71.43%3.79M | ---- | ---- | 6,430.54%13.26M | ---- | ---- | -79.58%203K | --994K |
| Depreciation and amortization | 9.70%1.07M | 26.16%979K | 29.10%244K | 40.85%231K | 802.33%776K | --189K | --164K | 30.30%86K | --66K |
| Other non cash items | 231.32%1.74M | -4,668.97%-1.33M | -100.14%-17.04M | 89.54%16.95M | 118.95%29K | ---8.52M | --8.94M | -1,375.00%-153K | --12K |
| Change In working capital | 911.73%2.49M | -152.48%-307K | -422.05%-2.51M | 99.85%-1K | -34.93%585K | --780K | ---667K | 1,504.69%899K | ---64K |
| -Change in prepaid assets | -84.49%201K | 174.83%1.3M | 220.75%1.02M | -387.24%-1.64M | -1,182.50%-1.73M | --318K | ---337K | 130.48%160K | ---525K |
| -Change in payables and accrued expense | 340.47%2.37M | -142.56%-986K | -864.50%-3.53M | 597.27%1.64M | 213.53%2.32M | --462K | ---330K | 60.30%739K | --461K |
| -Change in other current assets | 36.26%729K | --535K | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| -Change in other current liabilities | 29.77%-809K | ---1.15M | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | 24.80%-17.96M | -102.16%-23.88M | -290.49%-8.74M | -110.52%-6.59M | -62.90%-11.81M | ---2.24M | ---3.13M | -4.93%-7.25M | ---6.91M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | 120.77%18.68M | -566.64%-89.94M | -4,956.83%-92.38M | 51.07%-298K | 346.55%19.27M | 1.9M | -609K | 23.08%-7.82M | -10.16M |
| Net PPE purchase and sale | -608.08%-6.4M | 69.12%-904K | 36.96%-377K | 51.07%-298K | 22.30%-2.93M | ---598K | ---609K | -191.34%-3.77M | ---1.29M |
| Net investment purchase and sale | 131.71%28.24M | -501.05%-89.03M | ---- | ---- | 648.15%22.2M | ---- | ---- | 54.34%-4.05M | ---8.87M |
| Net other investing changes | ---3.15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | 120.77%18.68M | -566.64%-89.94M | -4,956.83%-92.38M | 51.07%-298K | 346.55%19.27M | --1.9M | ---609K | 23.08%-7.82M | ---10.16M |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | -94.53%5.3M | 87,201.80%96.91M | 73,975.00%14.82M | 8,198,400.00%81.99M | -99.62%111K | 20K | 1K | 450.76%29.32M | 5.32M |
| Net issuance payments of debt | --5.25M | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.25M |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --28.73M | --0 |
| Proceeds from stock option exercised by employees | -98.54%49K | 2,928.83%3.36M | 9,435.00%1.91M | 134,900.00%1.35M | -81.22%111K | --20K | --1K | -42.00%591K | --1.02M |
| Net other financing activities | ---- | --93.54M | --12.91M | --80.64M | ---- | ---- | ---- | ---- | ---946K |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | -94.53%5.3M | 87,201.80%96.91M | 73,975.00%14.82M | 8,198,400.00%81.99M | -99.62%111K | --20K | --1K | 450.76%29.32M | --5.32M |
| Net cash flow | |||||||||
| Beginning cash position | -71.97%6.69M | 47.48%23.85M | 732.98%98.91M | 47.48%23.85M | 778.54%16.17M | --11.87M | --16.17M | -86.47%1.84M | --13.61M |
| Current changes in cash | 135.61%6.02M | -323.32%-16.91M | -27,125.55%-86.31M | 2,110.22%75.1M | -46.86%7.57M | ---317K | ---3.74M | 221.27%14.25M | ---11.75M |
| Effect of exchange rate changes | 80.62%-50K | -338.89%-258K | -250.94%-240K | 91.49%-48K | 28.57%108K | --159K | ---564K | 566.67%84K | ---18K |
| End cash Position | 89.31%12.66M | -71.97%6.69M | 5.52%12.36M | 732.98%98.91M | 47.48%23.85M | --11.72M | --11.87M | 778.54%16.17M | --1.84M |
| Free cash flow | 1.71%-24.36M | -68.15%-24.78M | -221.47%-9.12M | -84.19%-6.88M | -33.77%-14.74M | ---2.84M | ---3.74M | -34.32%-11.02M | ---8.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg